insights_auto
Why is INO down 16,21%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,22 $
arrow_downward
-16,21%(-0,24) 1D
1,27 $
arrow_upward
+4,53% (+0,055)bedtimeAfter hours
Closed: 6 қар., 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,12 $
High
1,27 $
Low
1,07 $
Mkt. cap
125,63 млн
Avg. vol.
16,17 млн
Volume
39,72 млн
52-wk high
2,72 $
52-wk low
0,56 $
EPS
-1,17 $
Beta
1,71
Shares outstanding
103,40 млн
No. of employees
112
Open
1,12 $
High
1,27 $
Low
1,07 $
Mkt. cap
125,63 млн
Avg. vol.
16,17 млн
Volume
39,72 млн
52-wk high
2,72 $
52-wk low
0,56 $
EPS
-1,17 $
Beta
1,71
Shares outstanding
103,40 млн
No. of employees
112
News stories
From web sources and news partners
News Corp
·
21 сағат бұрын
Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors
Investing.com
·
1 күн бұрын
Jefferies raises Inovio stock price target on regulatory win
Investing.com Nigeria
·
1 күн бұрын
Why is Inovio Pharmaceuticals stock plunging today? By Investing.com
Yahoo Finance
·
1 күн бұрын
Inovio stock tumbles 25% on $75M share offering
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc